Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.12M
2: EX-4.5 Instrument Defining the Rights of Security Holders HTML 176K
4: EX-21.1 Subsidiaries List HTML 52K
5: EX-22.1 Published Report re: Matters Submitted to a Vote HTML 29K
of Security Holders
6: EX-23.1 Consent of Expert or Counsel HTML 30K
7: EX-24.1 Power of Attorney HTML 34K
3: EX-18.1 Letter re: a Change in Accounting Principles or HTML 29K
Practices
8: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 33K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 31K
17: R1 Cover HTML 100K
18: R2 Consolidated Balance Sheets (Parenthetical) HTML 40K
19: R3 Consolidated Balance Sheets HTML 148K
20: R4 Consolidated Statements of Operations HTML 135K
21: R5 Consolidated Statements of Comprehensive Income HTML 74K
22: R6 Consolidated Statements of Cash Flows HTML 131K
23: R7 Consolidated Statements of Shareholders' Equity HTML 134K
24: R8 Consolidated Statements of Shareholders' Equity HTML 31K
(Parenthetical)
25: R9 Nature of Operations and Summary of Significant HTML 355K
Accounting Policies
26: R10 Restructuring (Notes) HTML 53K
27: R11 Goodwill and Intangible Assets HTML 79K
28: R12 Inventories, Net HTML 40K
29: R13 Property, Plant and Equipment HTML 55K
30: R14 Debt HTML 90K
31: R15 Additional Consolidated Balance Sheets Information HTML 62K
32: R16 Income Tax Expense HTML 142K
33: R17 Benefit Plans HTML 245K
34: R18 Contingencies HTML 61K
35: R19 Business Segment Information HTML 146K
36: R20 Common Shares HTML 45K
37: R21 Repurchases of Common Shares HTML 33K
38: R22 Share-Based Compensation HTML 70K
39: R23 Financial and Other Guarantees HTML 41K
40: R24 Forward and Swap Contracts HTML 49K
41: R25 Fair Value Measurements HTML 88K
42: R26 Business Acquisitions and Divestitures Business HTML 78K
Acquisitions and Divestitures (Notes)
43: R27 Reclassifications out of AOCI (Notes) HTML 74K
44: R28 Quarterly Results (Unaudited) HTML 97K
45: R29 COVID-19 Pandemic HTML 32K
46: R30 Pending Acquisition of Cantel Medical Corp (Notes) HTML 77K
47: R31 Schedule II - Valuation and Qualifying Accounts HTML 86K
48: R32 Nature of Operations and Summary of Significant HTML 173K
Accounting Policies (Policies)
49: R33 Contingencies Lease Policy (Policies) HTML 41K
50: R34 Nature of Operations and Summary of Significant HTML 333K
Accounting Policies (Tables)
51: R35 Restructuring (Tables) HTML 53K
52: R36 Goodwill and Intangible Assets (Tables) HTML 80K
53: R37 Inventories, Net (Tables) HTML 40K
54: R38 Property, Plant and Equipment (Tables) HTML 59K
55: R39 Debt (Tables) HTML 73K
56: R40 Additional Consolidated Balance Sheets Information HTML 62K
(Tables)
57: R41 Income Tax Expense (Tables) HTML 139K
58: R42 Benefit Plans (Tables) HTML 248K
59: R43 Contingencies lease tables (Tables) HTML 49K
60: R44 Business Segment Information (Tables) HTML 145K
61: R45 Common Shares (Tables) HTML 45K
62: R46 Share-Based Compensation (Tables) HTML 67K
63: R47 Financial and Other Guarantees (Tables) HTML 40K
64: R48 Forward and Swap Contracts (Tables) HTML 50K
65: R49 Fair Value Measurements (Tables) HTML 89K
66: R50 Business Acquisitions and Divestitures Business HTML 65K
Acquisitions and Divestitures (Tables)
67: R51 Reclassifications out of AOCI (Tables) HTML 74K
68: R52 Quarterly Results (Unaudited) (Tables) HTML 96K
69: R53 Nature of Operations and Summary of Siginificant HTML 184K
Accounting Policies (Details)
70: R54 Nature of Operations and Summary of Significant HTML 176K
Accounting Policies - Change in Accounting
Principle (Details)
71: R55 Restructuring (Details) HTML 73K
72: R56 Goodwill and Intangible Assets Narrative (Details) HTML 50K
73: R57 Goodwill and Intangible Assets Goodwill HTML 48K
Rollforward (Details)
74: R58 Goodwill and Intangible Assets Other Intangible HTML 50K
Assets (Details)
75: R59 Goodwill and Intangible Assets Future Amortization HTML 40K
of Intangible Assets (Details)
76: R60 Inventories, Net (Details) HTML 40K
77: R61 Property, Plant and Equipment (Details) HTML 68K
78: R62 Debt (Details) HTML 117K
79: R63 Debt 2017 Senior Notes (Details) HTML 79K
80: R64 Additional Consolidated Balance Sheets Information HTML 87K
(Details)
81: R65 Income Tax Expense (Details) HTML 204K
82: R66 Benefit Plans (Change in benefit obligations HTML 81K
funded status) (Details)
83: R67 Benefit Plans (Amounts recognized in balance HTML 43K
sheets) (Details)
84: R68 Benefit Plans (Amortize pre-tax amount AOCI) HTML 35K
(Details)
85: R69 Benefit Plans (Accumulated benefit obligation HTML 40K
exceeding the fair value of plan assets) (Details)
86: R70 Benefit Plans (Projected benefit obligation HTML 82K
exceeding the fair value of plan assets) (Details)
87: R71 Benefit Plans (Components of the annual net HTML 75K
periodic benefit cost) (Details)
88: R72 Benefit Plans (Assumptions used in calculating HTML 50K
benefit obligations and net periodic benefit cost)
(Details)
89: R73 Benefit Plans (Significant assumptions used to HTML 50K
determine the net periodic benefit costs)
(Details)
90: R74 Benefit Plans (Assumed long-term healthcare cost HTML 35K
trend rate) (Details)
91: R75 Benefit Plans (Targeted asset allocation of plan HTML 35K
assets and the actual allocation of plan assets)
(Details)
92: R76 Benefit Plans (Fair value of our pension benefits HTML 59K
plan assets) (Details)
93: R77 Benefit Plans (Expected payments to be made to HTML 58K
plan participants) (Details)
94: R78 Benefit Plans (Details Textual) HTML 44K
95: R79 Benefit Plans Benefit Plans (Rollforward of Level HTML 40K
3 assets) (Details)
96: R80 Contingencies (Details) HTML 76K
97: R81 Business Segment Information (Details) HTML 154K
98: R82 Common Shares (Details) HTML 48K
99: R83 Repurchases of Common Shares (Details) HTML 55K
100: R84 Share-Based Compensation (Details) HTML 136K
101: R85 Financial and Other Guarantees (Details) HTML 34K
102: R86 Forward and Swap Contracts (Details) HTML 60K
103: R87 Fair Value Measurements (Details) HTML 89K
104: R88 Business Acquisitions and Divestitures Business HTML 133K
Acquisitions and Divestitures Narrative (Details)
105: R89 Business Acquisitions and Divestitures Synergy HTML 34K
Consideration (Details)
106: R90 Business Acquisitions and Divestitures Synergy HTML 32K
Acquisition (Details)
107: R91 Business Acquisitions and Divestitures Business HTML 95K
Acquisition Summary (Details)
108: R92 Reclassifications out of AOCI (Details) HTML 66K
109: R93 Accumulated Other Comprehensive Incom (Details) HTML 33K
110: R94 Quarterly Results (Unaudited) (Details) HTML 103K
111: R95 Pending Acquisition of Cantel Medical Corp HTML 43K
(Details)
112: R96 Schedule II - Valuation and Qualifying Accounts HTML 53K
(Details)
114: XML IDEA XML File -- Filing Summary XML 211K
16: XML XBRL Instance -- ste-20210331_htm XML 6.02M
113: EXCEL IDEA Workbook of Financial Reports XLSX 197K
12: EX-101.CAL XBRL Calculations -- ste-20210331_cal XML 167K
13: EX-101.DEF XBRL Definitions -- ste-20210331_def XML 1.43M
14: EX-101.LAB XBRL Labels -- ste-20210331_lab XML 2.87M
15: EX-101.PRE XBRL Presentations -- ste-20210331_pre XML 1.86M
11: EX-101.SCH XBRL Schema -- ste-20210331 XSD 270K
115: JSON XBRL Instance as JSON Data -- MetaLinks 654± 956K
116: ZIP XBRL Zipped Folder -- 0001757898-21-000017-xbrl Zip 668K
1.I have reviewed this annual report on Form 10-K of STERIS plc;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.